PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
242.97%
Growth of 242.97% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
262.43%
Cost growth of 262.43% versus flat Healthcare costs. Walter Schloss would verify cost control.
191.95%
Growth of 191.95% versus flat Healthcare gross profit. Walter Schloss would verify quality.
-14.88%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-63.20%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
149.83%
G&A change of 149.83% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
-15.82%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-103.97%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
81.88%
Operating expenses growth exceeding 1.5x Healthcare median of 0.54%. Jim Chanos would check for waste.
149.15%
Total costs growth exceeding 1.5x Healthcare median of 1.14%. Jim Chanos would check for waste.
15.31%
Interest expense change of 15.31% versus flat Healthcare costs. Walter Schloss would verify control.
38.60%
D&A growth exceeding 1.5x Healthcare median of 0.97%. Jim Chanos would check for overinvestment.
-269.53%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-116.66%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-318.21%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-21.94%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-102.79%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-292.84%
Pre-tax income decline while Healthcare median is 0.60%. Seth Klarman would investigate causes.
-156.23%
Pre-tax margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-246.51%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-299.52%
Net income decline while Healthcare median is 0.21%. Seth Klarman would investigate causes.
-158.17%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-295.00%
EPS decline while Healthcare median is 5.08%. Seth Klarman would investigate causes.
-295.00%
Diluted EPS decline while Healthcare median is 5.00%. Seth Klarman would investigate causes.
2.15%
Share count reduction below 50% of Healthcare median of 0.20%. Jim Chanos would check for issues.
0.34%
Diluted share reduction below 50% of Healthcare median of 0.19%. Jim Chanos would check for issues.